November 15, 2012 / 11:26 AM / in 5 years

Slovene Krka 9-mo group net down by 3 pct

LJUBLJANA, Nov 15 (Reuters) - Generic drugs producer, Krka , Slovenia’s largest listed company, posted a nine-month group net profit of 111.5 million euros ($141.92 million), down 3 percent compared with the same period last year due to higher costs.

The company also said sales rose by 6 percent to 813.9 million euros and forecast sales would reach 1.2 billion euros in 2013, a rise of 6 percent compared with the expected sales in 2012. ($1 = 0.7856 euros) (Reporting By Marja Novak; Editing by Zoran Radosavljevic and Alison Birrane)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below